Lv2
108 积分 2024-11-24 加入
Unlocking the potential of THR-β agonist therapies: resmetirom’s chemistry, biology, and patent insights
8天前
已完结
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy
8天前
已完结
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
8天前
已完结
IFNα regulates NK cell cytotoxicity through STAT1 pathway
8天前
已完结
Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently
8天前
已完结
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
8天前
已完结
Crosstalk network among multiple inflammatory mediators in liver fibrosis
9天前
已完结
P5 Pegozafermin treatment demonstrates long-term benefit in subjects with metabolic dysfunction-associated steatohepatitis and fibrosis: results from the Phase 2b ENLIVEN clinical trial
9天前
已完结
“The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the Liver
9天前
已完结
Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling
9天前
已完结
皖公网安备34019202002308
